CMCC

Major milestone for Canadian cannabis company & CMCC member Peace Naturals!

Cronos cracks the Nasdaq, a first for Canadian cannabis Ma*****na producer makes its debut on the U.S. exchange despite nagging doubts among American investors

Today, Philippe Lucas, CMCC’s executive director and Tilray's vice-president of patient access and research, met with the House of Commons Health Committee as part of its full-day hearings on Bill C-45, the federal government’s legalization of cannabis for recreational use. Lucas urged the committee to remove taxes on medical cannabis, shared data on the substitution of cannabis for opioids and alcohol, and suggested responsible branding directed at adults would maximize the benefit of legalization by helping to differentiate between legal and illegal supply.

A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evaluation are prioritized in order to guide health policy related to the federal government’s plans to legalize and regulate the adult use of cannabis.

Evaluation of legal cannabis must be prioritized to protect public health: Researchers Leading Canadian researchers call on federal government to prioritize research to maximize benefits and mitigate harms of legal cannabis Vancouver, BC [June 19, 2017]—A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evalu

Study shows lower rates of and among patients who supplement or replace treatment with medical :

Medical cannabis may not only ease suffering, but also save lives. Lower rates of depression and anxiety among patients who supplement or replace treatment with medical cannabis.